| # | Title | Journal | Year | Citations |
|---|
| 1 | Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma | Cancer Cell | 2010 | 2,078 |
| 2 | Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data | Lancet Oncology, The | 2010 | 1,532 |
| 3 | Cervical cancer | Lancet, The | 2019 | 1,367 |
| 4 | Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials | Lancet Oncology, The | 2015 | 1,220 |
| 5 | m 6 A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program | Cancer Cell | 2017 | 1,131 |
| 6 | Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial | Lancet, The | 2019 | 879 |
| 7 | Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study | Lancet Oncology, The | 2016 | 865 |
| 8 | Cervical cancer: A global health crisis | Cancer | 2017 | 790 |
| 9 | Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression | Nature Communications | 2014 | 780 |
| 10 | Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial | Neuro-Oncology | 2013 | 746 |
| 11 | Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease | Journal of the American College of Surgeons | 2008 | 740 |
| 12 | State-of-the-art strategies for targeting the DNA damage response in cancer | Nature Reviews Clinical Oncology | 2019 | 736 |
| 13 | Response assessment criteria for brain metastases: proposal from the RANO group | Lancet Oncology, The | 2015 | 711 |
| 14 | Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images | Cell Reports | 2018 | 683 |
| 15 | Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines | Radiotherapy and Oncology | 2014 | 585 |
| 16 | Estimated Projection of US Cancer Incidence and Death to 2040 | JAMA Network Open | 2021 | 566 |
| 17 | Validation of an accelerated ‘demons’ algorithm for deformable image registration in radiation therapy | Physics in Medicine and Biology | 2005 | 537 |
| 18 | Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial | Lancet Oncology, The | 2017 | 537 |
| 19 | Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement | Practical Radiation Oncology | 2017 | 483 |
| 20 | The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant | Cancer Treatment Reviews | 2015 | 482 |
| 21 | Early Detection of Pancreatic Cancer: Opportunities and Challenges | Gastroenterology | 2019 | 476 |
| 22 | American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guideline for the Performance of Stereotactic Body Radiation Therapy | International Journal of Radiation Oncology Biology Physics | 2010 | 473 |
| 23 | Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth? | Stem Cells | 2011 | 466 |
| 24 | Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators | Cancer | 2012 | 457 |
| 25 | Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline | Practical Radiation Oncology | 2018 | 431 |
| 26 | International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment | Annals of Oncology | 2011 | 407 |
| 27 | Integrating genomic features for non-invasive early lung cancer detection | Nature | 2020 | 379 |
| 28 | ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1 | Nature Cell Biology | 2014 | 367 |
| 29 | Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non–Small-Cell Lung Cancer | Journal of Clinical Oncology | 2013 | 366 |
| 30 | Breast Conservation After Neoadjuvant Chemotherapy: The M.D. Anderson Cancer Center Experience | Journal of Clinical Oncology | 2004 | 359 |
| 31 | Nanoparticle-mediated hyperthermia in cancer therapy | Therapeutic Delivery | 2011 | 346 |
| 32 | Improving immune–vascular crosstalk for cancer immunotherapy | Nature Reviews Immunology | 2018 | 340 |
| 33 | Improved survival time trends for glioblastoma using the SEER 17 population-based registries | Journal of Neuro-Oncology | 2012 | 332 |
| 34 | Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications | Radiotherapy and Oncology | 2010 | 325 |
| 35 | Double hit lymphoma: the MD Anderson Cancer Center clinical experience | British Journal of Haematology | 2014 | 310 |
| 36 | Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes | Nature Biotechnology | 2021 | 306 |
| 37 | Proton therapy – Present and future | Advanced Drug Delivery Reviews | 2017 | 303 |
| 38 | Hilar Cholangiocarcinoma: expert consensus statement | Hpb | 2015 | 298 |
| 39 | Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1–2 trial | Lancet Oncology, The | 2012 | 289 |
| 40 | Lymphopenia Association With Gross Tumor Volume and Lung V5 and Its Effects on Non-Small Cell Lung Cancer Patient Outcomes | International Journal of Radiation Oncology Biology Physics | 2014 | 285 |
| 41 | Late dysphagia after radiotherapy‐based treatment of head and neck cancer | Cancer | 2012 | 284 |
| 42 | Standard for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma | Ca-A Cancer Journal for Clinicians | 2002 | 283 |
| 43 | Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions | Frontiers in Pharmacology | 2018 | 277 |
| 44 | IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas | Acta Neuropathologica | 2015 | 272 |
| 45 | Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors? | Cancer Immunology Research | 2014 | 270 |
| 46 | Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer | Gastroenterology | 2019 | 270 |
| 47 | Influence of Technologic Advances on Outcomes in Patients With Unresectable, Locally Advanced Non–Small-Cell Lung Cancer Receiving Concomitant Chemoradiotherapy | International Journal of Radiation Oncology Biology Physics | 2010 | 269 |
| 48 | Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression | Clinical Cancer Research | 2019 | 268 |
| 49 | Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years | JAMA - Journal of the American Medical Association | 2017 | 261 |
| 50 | Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells | Clinical Cancer Research | 2017 | 261 |
